PathoGenetix, Inc.




Company Profile


PathoGenetix is developing products and applications based on its proprietary Genome Sequence Scanning™ (GSS™) technology, which was initially developed to detect bio-threat pathogens in environmental samples.

The Genome Sequence Scanning technology has a long history of published research documenting the development of its basic principles, components and processes. PathoGenetix is exploring application of the GSS technology for rapid bacterial identification and strain typing in markets such as food safety testing, industrial microbiology, and clinical diagnostics and research.